Tharimmune Files 8-K with Regulatory Updates
Ticker: CNTN · Form: 8-K · Filed: Sep 30, 2024 · CIK: 1861657
| Field | Detail |
|---|---|
| Company | Tharimmune, INC. (CNTN) |
| Form Type | 8-K |
| Filed Date | Sep 30, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, corporate-update
TL;DR
THARIMMUNE files 8-K: Regulatory updates, financial statements, and other events reported as of Sept 30, 2024.
AI Summary
Tharimmune, Inc. filed an 8-K on September 30, 2024, reporting on various events including Regulation FD disclosures, other events, and financial statements. The company, formerly known as Hillstream BioPharma Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides crucial updates on Tharimmune's corporate activities and financial reporting, which are important for investors to understand the company's current status and regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting on corporate events and financial statements, not indicating immediate significant operational changes or financial distress.
Key Numbers
- 001-41210 — SEC File Number (Identifies the company's filing with the SEC.)
- 84-2642541 — IRS Number (Company's Employer Identification Number.)
Key Players & Entities
- Tharimmune, Inc. (company) — Registrant
- Hillstream BioPharma Inc. (company) — Former company name
- 20240930 (date) — Report date
- 001-41210 (company) — SEC File Number
- 84-2642541 (company) — I. R. S. Employer Identification No.
FAQ
What specific events are detailed in the Regulation FD Disclosure section?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text snippet.
What are the key items reported under 'Other Events'?
The filing lists 'Other Events' as a category, but the specific nature of these events is not detailed in the provided text.
When was Tharimmune, Inc. formerly known as Hillstream BioPharma Inc.?
The company's name change from Hillstream BioPharma Inc. to Tharimmune, Inc. occurred on September 25, 2023.
What is Tharimmune, Inc.'s principal executive office address?
Tharimmune, Inc.'s principal executive offices are located at 1200 Route 22 East, Suite 2000, Bridgewater, NJ 08807.
What is the SIC code for Tharimmune, Inc.?
The Standard Industrial Classification (SIC) code for Tharimmune, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 730 words · 3 min read · ~2 pages · Grade level 11.9 · Accepted 2024-09-30 10:00:54
Key Financial Figures
- $0.0001 — nge on which registered Common stock, $0.0001 par value THAR The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 23KB
- ex99-2.htm (EX-99.2) — 24KB
- ex99-1_001.jpg (GRAPHIC) — 364KB
- ex99-1_002.jpg (GRAPHIC) — 684KB
- ex99-1_003.jpg (GRAPHIC) — 356KB
- ex99-1_004.jpg (GRAPHIC) — 347KB
- ex99-1_005.jpg (GRAPHIC) — 250KB
- ex99-1_006.jpg (GRAPHIC) — 290KB
- ex99-1_007.jpg (GRAPHIC) — 398KB
- ex99-1_008.jpg (GRAPHIC) — 395KB
- ex99-1_009.jpg (GRAPHIC) — 376KB
- ex99-1_010.jpg (GRAPHIC) — 292KB
- ex99-1_011.jpg (GRAPHIC) — 295KB
- ex99-1_012.jpg (GRAPHIC) — 258KB
- ex99-1_013.jpg (GRAPHIC) — 273KB
- ex99-1_014.jpg (GRAPHIC) — 347KB
- ex99-1_015.jpg (GRAPHIC) — 312KB
- ex99-1_016.jpg (GRAPHIC) — 292KB
- ex99-1_017.jpg (GRAPHIC) — 293KB
- ex99-1_018.jpg (GRAPHIC) — 347KB
- ex99-2_001.jpg (GRAPHIC) — 7KB
- 0001493152-24-038730.txt ( ) — 8779KB
- thar-20240930.xsd (EX-101.SCH) — 3KB
- thar-20240930_lab.xml (EX-101.LAB) — 33KB
- thar-20240930_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 30, 2024 Hillstream BioPharma, Inc. /s/ Randy Milby Randy Milby Chief Executive Officer -3-